2-(trifluoromethyl)pyrimidine-5-carboxamide - CAS 1378340-42-1
Catalog: |
BB056995 |
Product Name: |
2-(trifluoromethyl)pyrimidine-5-carboxamide |
CAS: |
1378340-42-1 |
Synonyms: |
2-(trifluoromethyl)pyrimidine-5-carboxamide; S7J |
IUPAC Name: | 2-(trifluoromethyl)pyrimidine-5-carboxamide |
Molecular Weight: | 191.11 |
Molecular Formula: | C6H4N3OF3 |
Canonical SMILES: | C1=C(C=NC(=N1)C(F)(F)F)C(=O)N |
InChI: | InChI=1S/C6H4F3N3O/c7-6(8,9)5-11-1-3(2-12-5)4(10)13/h1-2H,(H2,10,13) |
InChI Key: | OKRNBFHZDGTDRX-UHFFFAOYSA-N |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021250531-A1 | 4-(4,5-dihydro-1h-pyrazol-1-yl)pyrimidine compound as cannabinoid receptor (cb1 receptor) antagonists and pharmaceutical composition including same | 20200608 |
WO-2021154902-A1 | Collagen 1 translation inhibitors and methods of use thereof | 20200130 |
KR-102006547-B1 | Benzamide derivatives compounds, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory disease as an active ingredient | 20171116 |
KR-20190056070-A | Benzamide derivatives compounds, preparation method thereof, and pharmaceutical composition for use in preventing or treating inflammatory disease as an active ingredient | 20171116 |
WO-2019098738-A1 | Benzamide derivative compound, method for preparing same, and pharmaceutical composition for treating or preventing inflammatory disease containing same as active ingredient | 20171116 |
WO-2015195922-A1 | Compounds for use in treating acute coronary syndrome and related conditions | 20140619 |
WO-2014062938-A1 | Rory modulators | 20121019 |
AU-2013326429-A1 | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | 20121001 |
CA-2884922-A1 | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | 20121001 |
KR-20150063152-A | N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists | 20121001 |
Complexity: | 198 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 191.03064625 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 191.03064625 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 68.9Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0 |
-
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
-
Catalog: BB069926
((2R,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB055105
((2R,5S,10aS,10bS)-5-Benzyl-8,10b-bis(benzyloxy)-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB061033
((2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB064244
((2S,3R)-4-(4-(((((3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl)oxy)carbonyl)amino)-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamic Acid Phenylmethyl Ester
Detail
-
Catalog: BB067784
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine
Detail
-
Catalog: BB069173
((1-Chloro-2-methylpropan-2-yl)oxy)trimethylsilane
Detail
-
Catalog: BB072640
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS